Richwood Investment Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
Richwood Investment Advisors's BMY Position: Q1 2026 in Review
Richwood Investment Advisors reduced its Bristol-Myers Squibb (BMY) stake by 3.7% in Q1 2026, selling an estimated $23.9K and leaving 10,597 shares worth $643K. The position accounts for 0.5% of the portfolio, ranked #48.
Richwood Investment Advisors first reported a position in BMY in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.18M in Q2 2022. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Richwood Investment Advisors held 10,597 shares of Bristol-Myers Squibb worth $643K as of Q1 2026.
- Richwood Investment Advisors sold 410 Bristol-Myers Squibb shares in Q1 2026, an estimated $23.9K.
- Bristol-Myers Squibb made up 0.5% of Richwood Investment Advisors's portfolio in Q1 2026, its #48 holding.
- Richwood Investment Advisors first reported a position in Bristol-Myers Squibb in Q4 2021 and has held it in 18 quarters since.
- Richwood Investment Advisors's Bristol-Myers Squibb position peaked at $1.18M in Q2 2022.
- 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Richwood Investment Advisors's 13F filing for Q1 2026, filed 15 May 2026.